tTMB-P4(21.09) Reference Standard

CBP80001-4

詢價

索取COA

產(chǎn)品描述

產(chǎn)品數(shù)據(jù)庫

I. Background

Tumor mutational burden (TMB) shows great promise as a biomarker for immuno-oncology (I-O) therapy response, but progress is hindered by the lack of a standardized TMB measurement by targeted NGS panels, and an absence of TMB reference materials.

Sample ID	Cat.No.	Background	Assay	Comments
DC198N0163	CBP80001-4N	B lymphoblast, male	500x WES	Same individual
DC198N0162	CBP80001-4T	Lung large cell carcinoma, male	500x WES	Same individual
IDT xGenExome Research Panel v1.0捕獲，Target Region 39M, Probe Region 51M, CDS Region 33.52M; HiSeq X-TEN，af選擇0.02 cut off，再過濾。 DC198N0162 is 100% Tumor sample.

	Cut off =2%	Cut off =3%	Cut off =4%	Cut off =5%
Mutation Number	707	698	691	688
TMB value	21.09	20.82	20.61	20.53

計(jì)算數(shù)據(jù)下載：DC198N0162.tmb

相關(guān)產(chǎn)品推薦

? bTMB-P1 (22.91) Reference Standard ? TMB Reference Standard ? tTMB-P1(5.37) Reference Standard ? tTMB-P2(9.84) Reference Standard ? tTMB-P3(12.41) Reference Standard ? tTMB-P5(27.15) Reference Standard ? tTMB-P6(8.98) Reference Standard ? tTMB-P7(6.83) Reference Standard ? tTMB-P8(27.15) Reference Standard ? tTMB-P9(matrix) Reference Standard

上一篇：tTMB-P3(12.41) Reference Standard

下一篇：tTMB-P5(27.15) Reference Standard

返回列表